3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Melanoma, Amelanotic

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Melanoma, Amelanotic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Larisch, R; Müller-Gärtner, HW; Ruzicka, T; Schulte, KW; Vosberg, H	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Melanoma, Amelanotic

Article	Year
Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Contrast Media; Female; Humans; Iodine Radioisotopes; Male; Melanins; Melanoma; Melanoma, Amelanotic; Middle Aged; Prospective Studies; Pyrrolidines; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	1998

Article

Year

Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Benzamides; Contrast Media; Female; Humans; Iodine Radioisotopes; Male; Melanins; Melanoma; Melanoma, Amelanotic; Middle Aged; Prospective Studies; Pyrrolidines; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1998